What is Cryo-Cell International Price-to-Operating-Cash-Flow?
As of today (2024-05-27), Cryo-Cell International's share price is €7.60.
Cryo-Cell International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2024 was €0.77. Hence, Cryo-Cell International's Price-to-Operating-Cash-Flow Ratio for today is 9.92.
The historical rank and industry rank for Cryo-Cell International's Price-to-Operating-Cash-Flow or its related term are showing as below:
FRA:ZCY'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.94 Med: 9.22 Max: 295
Current: 10.85
During the past 13 years, Cryo-Cell International's highest Price-to-Operating-Cash-Flow Ratio was 295.00. The lowest was 2.94. And the median was 9.22.
Cryo-Cell International's Cash Flow from Operations per share for the
three
months ended in Feb. 2024 was €-0.04.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2024 was €0.77.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Cryo-Cell International was -19.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 0.90% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.40% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 24.30% per year.
During the past 13 years, Cryo-Cell International's highest 3-Year average Operating Cash Flow per Share Growth Rate was 149.20% per year. The lowest was -53.50% per year. And the median was 11.70% per year.
Cryo-Cell International Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Cryo-Cell International's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryo-Cell International Price-to-Operating-Cash-Flow Chart
|
Cryo-Cell International Annual Data
|
|
Trend |
Nov14 |
Nov15 |
Nov16 |
Nov17 |
Nov18 |
Nov19 |
Nov20 |
Nov21 |
Nov22 |
Nov23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
10.09 |
7.21 |
13.06 |
4.33 |
5.00 |
|
Cryo-Cell International Quarterly Data
|
|
May19 |
Aug19 |
Nov19 |
Feb20 |
May20 |
Aug20 |
Nov20 |
Feb21 |
May21 |
Aug21 |
Nov21 |
Feb22 |
May22 |
Aug22 |
Nov22 |
Feb23 |
May23 |
Aug23 |
Nov23 |
Feb24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
3.72 |
4.67 |
6.30 |
5.00 |
6.24 |
Competitive Comparison of Cryo-Cell International's Price-to-Operating-Cash-Flow
For the Medical Care Facilities subindustry, Cryo-Cell International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryo-Cell International's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Cryo-Cell International's Price-to-Operating-Cash-Flow falls into.
Cryo-Cell International Price-to-Operating-Cash-Flow Calculation
Cryo-Cell International's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 7.60 | / | 0.766 |
| = | 9.92 |
Cryo-Cell International's Share Price of today is €7.60.
Cryo-Cell International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.77.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Cryo-Cell International (FRA:ZCY) Business Description
Traded in Other Exchanges
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Cryo-Cell International (FRA:ZCY) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:ZCY has been successfully added to your